Page last updated: 2024-08-25

oxazolidin-2-one and Skin Diseases, Bacterial

oxazolidin-2-one has been researched along with Skin Diseases, Bacterial in 65 studies

Research

Studies (65)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's28 (43.08)29.6817
2010's30 (46.15)24.3611
2020's7 (10.77)2.80

Authors

AuthorsStudies
Broyde, N; Chou, MZ; De Anda, CS; Duval, V; Feng, HP; Guiastrennec, B; Hardalo, C; Li, D; Ouerdani, A; Rizk, ML; Sabato, PE; Sears, PS1
De Anda, C; Fujimi, S; Kusachi, S; Mikamo, H; Nagashima, M; Oshima, N; Takase, A1
Huang, H; Yuan, H; Yuan, Z; Zhang, Y; Zhao, X1
Calabuig Muñoz, E; Castells Lao, G; Isernia, V; López Suñé, E; Mensa Pueyo, J; Mensa Vendrell, M; Morata Ruiz, L; Moreno Nuñez, L; Oltra Sempere, MR; Pasquau Liaño, J; Pedro-Botet Montoya, ML; Reynaga Sosa, EA; Salavert Lletí, M; Sequera Arquelladas, S; Soriano Viladomiu, A; Tasias Pitarch, M; Yuste Ara, JR1
Carena, AA; Stryjewski, ME1
Antadze, T; Bradley, JS; Broyde, N; Butterton, JR; Chou, MZ; De Anda, CS; Kim, JY; Ninov, B; Sears, PS; Tayob, MS1
Kase, M; Kitaoka, A; Kobayashi, S; Matsubara, M; Yasu, T1
Bensaci, M; Corey, R; De Anda, C; Goering, R; Moran, G; Prokocimer, P; Sandison, T1
Antão, HS; Froes, F; Gonçalves-Pereira, J; Guimarães, JP; Santos, FP1
Chen, X; Dong, BR; Liu, GJ; Wu, T; Yang, M; Yue, J1
Bien, P; De Anda, C; Prokocimer, P1
Boucher, HW; Das, AF; Dunne, MW; Puttagunta, S; Talbot, GH; Wilcox, M1
Corey, GR; Das, AF; De Anda, C; Fang, E; Moran, GJ; Prokocimer, P1
Kern, WV; Tacconelli, E1
Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ1
Fiedler-Kelly, J; Flanagan, S; Lu, Q; Ludwig, E; Passarell, J; Prokocimer, P1
Holmes, NE; Howden, BP1
Steiner, M1
Corey, GR; Das, AF; De Anda, C; Fang, E; Lodise, TP; Prokocimer, P; Shorr, AF1
Drekonja, DM2
Taylor, J1
Corey, GR; Das, AF; Moran, GJ; Prokocimer, P1
Cardona, AF; Wilson, SE1
Anuskiewicz, S; Culshaw, D; De Anda, C; Joseph, WS; Prokocimer, P1
Ferrández, O; Grau, S; Urbina, O1
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R1
Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X1
Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH1
Lustberg, ME; Mangino, JE; Schlesinger, LS1
Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C1
Stein, GE; Wells, EM1
Concia, E1
Curcio, D1
Ang, JY; Deville, JG; Equils, O; Huang, DB1
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J1
Gould, FK1
Clark, K; Corey, GR; Craft, JC; Das, A; Degenhardt, TP; Fernandes, P; Moriarty, SR; Scott, D; Still, JG1
Lin, YH; Liu, TC1
Almenoff, J; Andrae, D; Covington, P; Davenport, JM; Liverman, L; McIntyre, G; O'Riordan, W1
Dowzicky, MJ; Namdari, H; Tan, TY1
Arbeit, RD; Draper, MP; Hait, H; Noel, GJ; Tanaka, SK1
Hau, T1
Arya, SC1
Bruss, JB; Cammarata, SK; Le, V; Solomkin, JS; Wilson, SE1
Li, JZ; Rittenhouse, BE; Rybak, MJ; Willke, RJ1
Gauzit, R1
Scheinfeld, NS; Schweiger, ES; Tischler, HR; Weinberg, JM1
Adler, S; Bruss, JB; Edge-Padbury, B; Kaplan, SL; Martin, A; Morfin, MR; Naberhuis-Stehouwer, S; Patterson, LE; Yogev, R1
Bruss, JB; Edge-Padbury, B; Goldfarb, J; Kaplan, SA; Naberhuis-Stehouwer, S; Saiman, L; Wible, K1
Choi, SH; Gonzalez, E; Vera-Cabrera, L; Welsh, O1
Schweiger, ES; Weinberg, JM1
LaRosa, SP; Tomecki, KJ1
Chen, YS; Kim, WJ; Lee, SC1
Lerner, DS; Silverberg, NB; Weinberg, JM; Wesson, KM1
Kyle, SD; Porter, WM1
Citron, DM; Goldstein, EJ; Havlichek, DH; Kak, V; Peloquin, CA; Schooley, SL; Stein, GE; Tyrrell, KL1
Dryden, M; Itani, K; Knirsch, C; Lau, W; Stevens, D; Weigelt, J1
Wilcox, MH1
Babazadeh, S; Breaux, J; Endzinas, Z; Frederick, M; Goldberg, L; Jauregui, LE; Krause, D; Krievins, D; O'Riordan, W; Satilovs, I; Seltzer, E1
Charles, PG; Grayson, ML; Howden, BP; Johnson, PD; Ward, PB1
Scheinfeld, N1
Plouffe, JF1
Bruss, JB; Duvall, SE; Hafkin, B; McConnell-Martin, MA; Smith, LG; Stevens, DL; Todd, WM1
Hedström, SA1

Reviews

20 review(s) available for oxazolidin-2-one and Skin Diseases, Bacterial

ArticleYear
Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections.
    Expert review of clinical pharmacology, 2020, Volume: 13, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Drug Interactions; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles

2020
Linezolid versus vancomycin for skin and soft tissue infections.
    The Cochrane database of systematic reviews, 2013, Jul-12, Issue:7

    Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Eruptions; Humans; Length of Stay; Linezolid; Oxazolidinones; Pruritus; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Thrombocytopenia; Vancomycin

2013
What's new in the treatment of serious MRSA infection?
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2014
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Sep-15, Volume: 61 Suppl 2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Daptomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; North America; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections

2015
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Anti-Bacterial Agents; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Oxazolidinones; Skin Diseases, Bacterial; Streptococcus; Tetrazoles

2017
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2017
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin

2010
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Current medical research and opinion, 2010, Volume: 26, Issue:3

    Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2010
[Therapy of SSTI and role of tigecycline].
    Le infezioni in medicina, 2009, Volume: 17 Suppl 4

    Topics: Acetamides; Anti-Bacterial Agents; Combined Modality Therapy; Comorbidity; Cross Infection; Daptomycin; Debridement; Drainage; Drug Therapy, Combination; Humans; Italy; Linezolid; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Tigecycline; Wound Infection

2009
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
    Expert review of anti-infective therapy, 2010, Volume: 8, Issue:9

    Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Skin Diseases, Bacterial; Tigecycline; Treatment Outcome

2010
Linezolid: safety and efficacy in special populations.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66 Suppl 4

    Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United Kingdom

2011
Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:7

    Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Humans; Linezolid; Multicenter Studies as Topic; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections

2002
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
    Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Half-Life; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Virginiamycin

2003
Novel antibacterial agents for skin and skin structure infections.
    Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin

2004
Antibiotics: what's new?
    Cutis, 2004, Volume: 73, Issue:5 Suppl

    Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Streptogramins

2004
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Disease-a-month : DM, 2004, Volume: 50, Issue:7

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Oxazolidinones; Skin Diseases, Bacterial; Virginiamycin

2004
Update on linezolid: the first oxazolidinone antibiotic.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:13

    Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin

2005
Dalbavancin: a review for dermatologists.
    Dermatology online journal, 2006, May-30, Volume: 12, Issue:4

    Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin

2006
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31 Suppl 4

    Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial

2000
[Linezolide--an antibiotic with new action mechanism].
    Lakartidningen, 2002, Mar-14, Volume: 99, Issue:11

    Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections

2002

Trials

22 trial(s) available for oxazolidin-2-one and Skin Diseases, Bacterial

ArticleYear
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing ted
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Double-Blind Method; Hospitals; Humans; Japan; Linezolid; Organophosphates; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Skin Diseases, Bacterial; Tetrazoles; Ventilators, Mechanical

2022
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.
    The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Oxazolidinones; Pyridones; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome

2022
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
    The Pediatric infectious disease journal, 2021, 03-01, Volume: 40, Issue:3

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Female; Global Health; Humans; Male; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Wound Infection

2021
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.
    Surgical infections, 2014, Volume: 15, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Erythema; Humans; Image Interpretation, Computer-Assisted; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; United States

2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
    The New England journal of medicine, 2014, Jun-05, Volume: 370, Issue:23

    Topics: Acetamides; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Teicoplanin; Vancomycin; Young Adult

2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:8

    Topics: Acetamides; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult

2014
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections; Tetrazoles

2015
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:3

    Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin

2008
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jan-15, Volume: 48, Issue:2

    Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin

2009
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
    Clinical pediatrics, 2011, Volume: 50, Issue:11

    Topics: Acetamides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pediatrics; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2011
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult

2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 52 Suppl 7

    Topics: Acetamides; Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Cellulitis; Double-Blind Method; Drug Administration Schedule; Female; Fusidic Acid; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult

2011
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcus aureus; Treatment Outcome; United States; Young Adult

2011
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Minocycline; Oxazolidinones; Placebos; Skin; Skin Diseases, Bacterial; Staphylococcal Infections; Treatment Outcome

2012
Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
    Surgical infections, 2003,Spring, Volume: 4, Issue:1

    Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Length of Stay; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Probability; Prognosis; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcus aureus; Treatment Outcome; Vancomycin; Wound Infection

2003
Linezolid for the treatment of complicated skin and skin structure infections in children.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:9 Suppl

    Topics: Acetamides; Administration, Oral; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin

2003
Safety and tolerability of linezolid in children.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:9 Suppl

    Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefadroxil; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Gram-Positive Bacterial Infections; Headache; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Multicenter Studies as Topic; Otitis Media; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Skin Diseases, Bacterial

2003
Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2004, Volume: 103, Issue:5

    Topics: Acetamides; Cellulitis; Consumer Product Safety; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Protein Synthesis Inhibitors; Skin Diseases, Bacterial; Soft Tissue Infections

2004
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3

    Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cellulitis; Drug Resistance, Multiple, Bacterial; Female; Half-Life; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Obesity; Oxazolidinones; Serum Bactericidal Test; Skin Diseases, Bacterial; Soft Tissue Infections

2005
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6

    Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Humans; Internationality; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2005
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Nov-15, Volume: 41, Issue:10

    Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Teicoplanin; Time Factors

2005
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12

    Topics: Acetamides; Anti-Infective Agents; Dicloxacillin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxacillin; Oxazolidinones; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome

2000

Other Studies

23 other study(ies) available for oxazolidin-2-one and Skin Diseases, Bacterial

ArticleYear
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
    Antimicrobial agents and chemotherapy, 2021, 11-17, Volume: 65, Issue:12

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Humans; Oxazolidinones; Probability; Skin Diseases, Bacterial; Tetrazoles

2021
Safety and Tolerability of More than Six Days of Tedizolid Treatment.
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Anti-Bacterial Agents; Humans; Organophosphates; Oxazoles; Oxazolidinones; Retrospective Studies; Skin Diseases, Bacterial; Tetrazoles

2020
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.
    International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:9

    Topics: Anti-Bacterial Agents; Humans; Linezolid; Microbial Sensitivity Tests; Neutropenia; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Tetrazoles

2021
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.
    Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Treatment Outcome; Young Adult

2019
Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study.
    Acta medica portuguesa, 2019, Jun-28, Volume: 32, Issue:6

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Anti-Infective Agents; Comorbidity; Female; Humans; Length of Stay; Male; Middle Aged; Oxazolidinones; Patient Discharge; Portugal; Retrospective Studies; Skin Diseases, Bacterial; Thrombocytopenia

2019
New antibiotics for skin and skin-structure infections.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:8

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2014
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
    Journal of medical economics, 2014, Volume: 17, Issue:10

    Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin

2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Organophosphates; Oxazoles; Oxazolidinones; Platelet Count; Prodrugs; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Young Adult

2014
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.
    Evidence-based child health : a Cochrane review journal, 2014, Volume: 9, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin

2014
A closer inspection of tedizolid.
    The Lancet. Infectious diseases, 2015, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2015
A closer inspection of tedizolid.
    The Lancet. Infectious diseases, 2015, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2015
A closer inspection of tedizolid - authors' reply.
    The Lancet. Infectious diseases, 2015, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2015
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections
    Journal of the American Podiatric Medical Association, 2017, Volume: 107, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Tetrazoles; Treatment Outcome

2017
Noninferiority of linezolid for skin and bloodstream infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jul-15, Volume: 49, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biomedical Research; Catheterization; Humans; Linezolid; Oxazolidinones; Research Design; Skin Diseases, Bacterial

2009
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study".
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jul-15, Volume: 49, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Catheterization; Humans; Linezolid; Oxazolidinones; Skin Diseases, Bacterial

2009
Mycobacterium chelonae infection involving the auricle.
    QJM : monthly journal of the Association of Physicians, 2012, Volume: 105, Issue:10

    Topics: Acetamides; Adult; Anti-Infective Agents; Clarithromycin; Ear Auricle; Humans; Linezolid; Lymph Nodes; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neck; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome

2012
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin

2012
Therapeutic efficacy of linezolid in extended clinical practice.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:2

    Topics: Acetamides; Anti-Infective Agents; Drug Labeling; Drug Storage; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Assessment; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Temperature

2003
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.
    American journal of surgery, 2003, Volume: 185, Issue:4

    Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Cloxacillin; Female; Humans; Linezolid; Male; Middle Aged; Outcome Assessment, Health Care; Oxazolidinones; Penicillins; Prognosis; Risk; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Failure

2003
[Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues].
    Presse medicale (Paris, France : 1983), 2003, Apr-05, Volume: 32, Issue:13 Pt 2

    Topics: Acetamides; Anti-Infective Agents; Controlled Clinical Trials as Topic; France; Humans; Linezolid; Oxacillin; Oxazolidinones; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections

2003
In vitro activities of new antimicrobials against Nocardia brasiliensis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2

    Topics: Anti-Infective Agents; Humans; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Oxazolidinones; Skin Diseases, Bacterial; Sulfonamides

2004
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
    The British journal of dermatology, 2004, Volume: 151, Issue:5

    Topics: Acetamides; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Forearm; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Oxazolidinones; Skin Diseases, Bacterial

2004
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11

    Topics: Acetamides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2005